|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abstract
Embryonic stem cells are typically derived from the inner
cell mass of the preimplantation blastocyst, and can both
self-renew and differentiate into all the cells and
tissues of the embryo. Because they are pluripotent, ES
cells have been used extensively to analyze gene function
in development via gene targeting. The embryonic stem
cell is also an unsurpassed starting material to begin to
understand a critical, largely inaccessible period of
development. If their differentiation could be
controlled, they would also be an important source of
cells for transplantation to replace cells lost through
disease or injury, or to replace missing hormones or
genes. Traditionally, ES cells have been differentiated
in suspension culture as embryoid bodies, named because of
their similarity to the early post-implantation staged
embryo. Unlike the pristine organization of the early
embryo, differentiation in embryoid bodies appears to be
largely unpatterned, although multiple cell types form.
It has recently been possible to separate the desired cell
types from differentiating ES cells in embryoid bodies by
using cell-type restricted promoters driving expression of
either antibiotic resistance genes or fluorophores such as
EGFP. In combination with growth factor exposure, highly
differentiated cell types have successfully been derived
from ES cells. Recent technological advances such as RNA
interference to knock down gene expression in ES cells are
also producing enriched populations of cells and
elucidating gene function in early development.
Key words:
Embryo
Central Nervous System
Developmental biology
Early development
Growth factors
This article has been cited by other articles:
![]() |
M. P. Quinlan, S. E. Quatela, M. R. Philips, and J. Settleman Activated Kras, but Not Hras or Nras, May Initiate Tumors of Endodermal Origin via Stem Cell Expansion Mol. Cell. Biol., April 15, 2008; 28(8): 2659 - 2674. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Yocum, T. E. Gratsch, N. Leff, J. R. Strahler, C. L. Hunter, A. K. Walker, G. Michailidis, G. S. Omenn, K. S. O'Shea, and P. C. Andrews Coupled Global and Targeted Proteomics of Human Embryonic Stem Cells during Induced Differentiation Mol. Cell. Proteomics, April 1, 2008; 7(4): 750 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Torihashi, M. Kuwahara, T. Ogaeri, P. Zhu, M. Kurahashi, and T. Fujimoto Gut-Like Structures from Mouse Embryonic Stem Cells as an In Vitro Model for Gut Organogenesis Preserving Developmental Potential After Transplantation Stem Cells, December 1, 2006; 24(12): 2618 - 2626. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Matsuura, H. Kogo, T. Ogaeri, T. Miwa, M. Kuwahara, Y. Kanai, T. Nakagawa, A. Kuroiwa, T. Fujimoto, and S. Torihashi Crucial Transcription Factors in Endoderm and Embryonic Gut Development Are Expressed in Gut-Like Structures from Mouse ES Cells Stem Cells, March 1, 2006; 24(3): 624 - 630. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |